Ten-year outcomes of intensity-modulated radiation therapy combined with neoadjuvant hormonal therapy for intermediate- and high-risk patients with T1c-T2N0M0 prostate cancer

被引：0
|
作者：
Takashi Mizowaki
Yoshiki Norihisa
Kenji Takayama
Itaru Ikeda
Haruo Inokuchi
Kiyonao Nakamura
Tomomi Kamba
Takahiro Inoue
Toshiyuki Kamoto
Osamu Ogawa
Masahiro Hiraoka
机构：
[1] Kyoto University,Department of Radiation Oncology and Image
[2] Kyoto University,applied Therapy, Graduate School of Medicine
来源：
International Journal of Clinical Oncology | 2016年 / 21卷
关键词：
Localized prostate cancer; Neoadjuvant hormonal therapy; Intensity-modulated radiation therapy; Prostate-specific antigen failure-free survival; Overall survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：783 / 790
页数：7
相关论文
共 50 条
  • [21] The prevalence and outcomes of pT0 disease after neoadjuvant hormonal therapy and radical prostatectomy in high-risk prostate cancer
    Joung, Jae Young
    Kim, Jeong Eun
    Kim, Sung Han
    Seo, Ho Kyung
    Chung, Jinsoo
    Park, Weon Seo
    Hong, Eun Kyung
    Lee, Kang Hyun
    BMC UROLOGY, 2015, 15
  • [22] The prevalence and outcomes of pT0 disease after neoadjuvant hormonal therapy and radical prostatectomy in high-risk prostate cancer
    Jae Young Joung
    Jeong Eun Kim
    Sung Han Kim
    Ho Kyung Seo
    Jinsoo Chung
    Weon Seo Park
    Eun Kyung Hong
    Kang Hyun Lee
    BMC Urology, 15
  • [23] Urethral toxicity vs. cancer control-Lessons to be learned from high-dose rate brachytherapy combined with intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer
    Ghadjar, Pirus
    Rentsch, Cyrill A.
    Isaak, Bernhard
    Behrensmeier, Frank
    Thalmann, George N.
    Aebersold, Daniel M.
    BRACHYTHERAPY, 2011, 10 (04) : 286 - 294
  • [24] Addition of an oral docetaxel treatment (ModraDoc006/r) to androgen deprivation therapy (ADT) and intensity-modulated radiation therapy (IMRT) in patients with high risk N+M0 prostate cancer
    Vermunt, M. A. C.
    Janssen, J. M.
    Vrijenhoek, G. L.
    van der Poel, H. G.
    Thijssen, B.
    Beijnen, J. H.
    van Triest, B.
    ANNALS OF ONCOLOGY, 2019, 30
  • [25] Ten-Year Results From a Phase II Study on Image Guided, Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in High-Risk Prostate Cancer
    Ekanger, Christian
    Helle, Svein Inge
    Heinrich, Daniel
    Johannessen, Dag Clement
    Karlsdottir, Asa
    Nygard, Yngve
    Halvorsen, Ole Johan
    Reisaeter, Lars
    Kvale, Rune
    Hysing, Liv Bolstad
    Dahl, Olav
    ADVANCES IN RADIATION ONCOLOGY, 2020, 5 (03) : 396 - 403
  • [26] Optimisation of Radiation Therapy in Bladder Preservation Therapy for Patients With Clinical Stage T2N0M0 Bladder Cancer
    Nakata, M.
    Shimbo, T.
    Kihara, A.
    Sato, C.
    Hori, A.
    Yoshioka, H.
    Yoshida, K.
    Nihei, K.
    CLINICAL ONCOLOGY, 2022, 34 (10) : E430 - E436
  • [27] Trimodality Therapy Is Tolerable and Feasible in Patients With Postprostatectomy High-Risk Pathologic (p) T2-3N0M0 Prostate Cancer: Results of a Phase 1-2 Trial
    Kumar, P.
    Veldhuizen, P.
    Thompson, M.
    Shen, X.
    Pinski, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S186 - S186
  • [28] Phase I/III trial of combined hormonal therapy and hypofractionated accelerated radiotherapy with concomitant intensity-modulated boost for high-risk prostate cancer
    Quon, H.
    Loblaw, D. A.
    Morton, G.
    Szumacher, E.
    Danjoux, C.
    Choo, R.
    Thomas, G.
    Kiss, A.
    Deabreu, A.
    Cheung, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation
    Aizawa, Rihito
    Takayama, Kenji
    Nakamura, Kiyonao
    Inoue, Takahiro
    Yamasaki, Toshinari
    Kobayashi, Takashi
    Akamatsu, Shusuke
    Ogawa, Osamu
    Mizowaki, Takashi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (10) : 1247 - 1255
  • [30] Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation
    Rihito Aizawa
    Kenji Takayama
    Kiyonao Nakamura
    Takahiro Inoue
    Toshinari Yamasaki
    Takashi Kobayashi
    Shusuke Akamatsu
    Osamu Ogawa
    Takashi Mizowaki
    International Journal of Clinical Oncology, 2019, 24 : 1247 - 1255
12345